Report Detail

According to our (Global Info Research) latest study, the global New Chemical Entities (NCE) market size was valued at US$ 5136 million in 2025 and is forecast to a readjusted size of US$ 10570 million by 2032 with a CAGR of 11.0% during review period.
During the drug discovery process, new compounds or active moieties (molecules or ions responsible for physiological or pharmacological action) can arise that have not previously been FDA-approved. These compounds are called New Chemical Entities (NCE) as they have not previously been used, and they can help bring about cures and therapies for incurable diseases such as cancer due to the novelty of the drug and or compound.In the existing market, there are already companies providing CDMO services for new chemical entities, and there are also companies providing new chemical entity discovery services, which can then be handed over to other companies for drug development.
This report is a detailed and comprehensive analysis for global New Chemical Entities (NCE) market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global New Chemical Entities (NCE) market size and forecasts, in consumption value ($ Million), 2021-2032
Global New Chemical Entities (NCE) market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global New Chemical Entities (NCE) market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global New Chemical Entities (NCE) market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for New Chemical Entities (NCE)
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global New Chemical Entities (NCE) market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include KATSURA CHEMICAL CO., LTD, NMS Group (Accelera Srl), Adragos Pharma, Syngene, Regis Custom API, Bachem, Suven Pharma, Aspen API, MedPharm, Intertek, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
New Chemical Entities (NCE) market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
NCE Discovery
Drug Formulation Development
Large-scale Manufacturing
Market segment by Application
Tumors
Cardiovascular Diseases
Other
Market segment by players, this report covers
KATSURA CHEMICAL CO., LTD
NMS Group (Accelera Srl)
Adragos Pharma
Syngene
Regis Custom API
Bachem
Suven Pharma
Aspen API
MedPharm
Intertek
Neuland Laboratories
Piramal Pharma Solutions
Sai Life Sciences
Chempro Pharma
LG Chem
Sofpromed
Aurigene Pharmaceutical Services Ltd.
Aragen Life Sciences Ltd
WuXi AppTec
PharmaBlock Sciences Nanjing Inc
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe New Chemical Entities (NCE) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of New Chemical Entities (NCE), with revenue, gross margin, and global market share of New Chemical Entities (NCE) from 2021 to 2026.
Chapter 3, the New Chemical Entities (NCE) competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and New Chemical Entities (NCE) market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of New Chemical Entities (NCE).
Chapter 13, to describe New Chemical Entities (NCE) research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of New Chemical Entities (NCE) by Type
    • 1.3.1 Overview: Global New Chemical Entities (NCE) Market Size by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Global New Chemical Entities (NCE) Consumption Value Market Share by Type in 2025
    • 1.3.3 NCE Discovery
    • 1.3.4 Drug Formulation Development
    • 1.3.5 Large-scale Manufacturing
  • 1.4 Global New Chemical Entities (NCE) Market by Application
    • 1.4.1 Overview: Global New Chemical Entities (NCE) Market Size by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Tumors
    • 1.4.3 Cardiovascular Diseases
    • 1.4.4 Other
  • 1.5 Global New Chemical Entities (NCE) Market Size & Forecast
  • 1.6 Global New Chemical Entities (NCE) Market Size and Forecast by Region
    • 1.6.1 Global New Chemical Entities (NCE) Market Size by Region: 2021 VS 2025 VS 2032
    • 1.6.2 Global New Chemical Entities (NCE) Market Size by Region, (2021-2032)
    • 1.6.3 North America New Chemical Entities (NCE) Market Size and Prospect (2021-2032)
    • 1.6.4 Europe New Chemical Entities (NCE) Market Size and Prospect (2021-2032)
    • 1.6.5 Asia-Pacific New Chemical Entities (NCE) Market Size and Prospect (2021-2032)
    • 1.6.6 South America New Chemical Entities (NCE) Market Size and Prospect (2021-2032)
    • 1.6.7 Middle East & Africa New Chemical Entities (NCE) Market Size and Prospect (2021-2032)

2 Company Profiles

  • 2.1 KATSURA CHEMICAL CO., LTD
    • 2.1.1 KATSURA CHEMICAL CO., LTD Details
    • 2.1.2 KATSURA CHEMICAL CO., LTD Major Business
    • 2.1.3 KATSURA CHEMICAL CO., LTD New Chemical Entities (NCE) Product and Solutions
    • 2.1.4 KATSURA CHEMICAL CO., LTD New Chemical Entities (NCE) Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 KATSURA CHEMICAL CO., LTD Recent Developments and Future Plans
  • 2.2 NMS Group (Accelera Srl)
    • 2.2.1 NMS Group (Accelera Srl) Details
    • 2.2.2 NMS Group (Accelera Srl) Major Business
    • 2.2.3 NMS Group (Accelera Srl) New Chemical Entities (NCE) Product and Solutions
    • 2.2.4 NMS Group (Accelera Srl) New Chemical Entities (NCE) Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 NMS Group (Accelera Srl) Recent Developments and Future Plans
  • 2.3 Adragos Pharma
    • 2.3.1 Adragos Pharma Details
    • 2.3.2 Adragos Pharma Major Business
    • 2.3.3 Adragos Pharma New Chemical Entities (NCE) Product and Solutions
    • 2.3.4 Adragos Pharma New Chemical Entities (NCE) Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Adragos Pharma Recent Developments and Future Plans
  • 2.4 Syngene
    • 2.4.1 Syngene Details
    • 2.4.2 Syngene Major Business
    • 2.4.3 Syngene New Chemical Entities (NCE) Product and Solutions
    • 2.4.4 Syngene New Chemical Entities (NCE) Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Syngene Recent Developments and Future Plans
  • 2.5 Regis Custom API
    • 2.5.1 Regis Custom API Details
    • 2.5.2 Regis Custom API Major Business
    • 2.5.3 Regis Custom API New Chemical Entities (NCE) Product and Solutions
    • 2.5.4 Regis Custom API New Chemical Entities (NCE) Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Regis Custom API Recent Developments and Future Plans
  • 2.6 Bachem
    • 2.6.1 Bachem Details
    • 2.6.2 Bachem Major Business
    • 2.6.3 Bachem New Chemical Entities (NCE) Product and Solutions
    • 2.6.4 Bachem New Chemical Entities (NCE) Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Bachem Recent Developments and Future Plans
  • 2.7 Suven Pharma
    • 2.7.1 Suven Pharma Details
    • 2.7.2 Suven Pharma Major Business
    • 2.7.3 Suven Pharma New Chemical Entities (NCE) Product and Solutions
    • 2.7.4 Suven Pharma New Chemical Entities (NCE) Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Suven Pharma Recent Developments and Future Plans
  • 2.8 Aspen API
    • 2.8.1 Aspen API Details
    • 2.8.2 Aspen API Major Business
    • 2.8.3 Aspen API New Chemical Entities (NCE) Product and Solutions
    • 2.8.4 Aspen API New Chemical Entities (NCE) Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Aspen API Recent Developments and Future Plans
  • 2.9 MedPharm
    • 2.9.1 MedPharm Details
    • 2.9.2 MedPharm Major Business
    • 2.9.3 MedPharm New Chemical Entities (NCE) Product and Solutions
    • 2.9.4 MedPharm New Chemical Entities (NCE) Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 MedPharm Recent Developments and Future Plans
  • 2.10 Intertek
    • 2.10.1 Intertek Details
    • 2.10.2 Intertek Major Business
    • 2.10.3 Intertek New Chemical Entities (NCE) Product and Solutions
    • 2.10.4 Intertek New Chemical Entities (NCE) Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Intertek Recent Developments and Future Plans
  • 2.11 Neuland Laboratories
    • 2.11.1 Neuland Laboratories Details
    • 2.11.2 Neuland Laboratories Major Business
    • 2.11.3 Neuland Laboratories New Chemical Entities (NCE) Product and Solutions
    • 2.11.4 Neuland Laboratories New Chemical Entities (NCE) Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Neuland Laboratories Recent Developments and Future Plans
  • 2.12 Piramal Pharma Solutions
    • 2.12.1 Piramal Pharma Solutions Details
    • 2.12.2 Piramal Pharma Solutions Major Business
    • 2.12.3 Piramal Pharma Solutions New Chemical Entities (NCE) Product and Solutions
    • 2.12.4 Piramal Pharma Solutions New Chemical Entities (NCE) Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Piramal Pharma Solutions Recent Developments and Future Plans
  • 2.13 Sai Life Sciences
    • 2.13.1 Sai Life Sciences Details
    • 2.13.2 Sai Life Sciences Major Business
    • 2.13.3 Sai Life Sciences New Chemical Entities (NCE) Product and Solutions
    • 2.13.4 Sai Life Sciences New Chemical Entities (NCE) Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 Sai Life Sciences Recent Developments and Future Plans
  • 2.14 Chempro Pharma
    • 2.14.1 Chempro Pharma Details
    • 2.14.2 Chempro Pharma Major Business
    • 2.14.3 Chempro Pharma New Chemical Entities (NCE) Product and Solutions
    • 2.14.4 Chempro Pharma New Chemical Entities (NCE) Revenue, Gross Margin and Market Share (2021-2026)
    • 2.14.5 Chempro Pharma Recent Developments and Future Plans
  • 2.15 LG Chem
    • 2.15.1 LG Chem Details
    • 2.15.2 LG Chem Major Business
    • 2.15.3 LG Chem New Chemical Entities (NCE) Product and Solutions
    • 2.15.4 LG Chem New Chemical Entities (NCE) Revenue, Gross Margin and Market Share (2021-2026)
    • 2.15.5 LG Chem Recent Developments and Future Plans
  • 2.16 Sofpromed
    • 2.16.1 Sofpromed Details
    • 2.16.2 Sofpromed Major Business
    • 2.16.3 Sofpromed New Chemical Entities (NCE) Product and Solutions
    • 2.16.4 Sofpromed New Chemical Entities (NCE) Revenue, Gross Margin and Market Share (2021-2026)
    • 2.16.5 Sofpromed Recent Developments and Future Plans
  • 2.17 Aurigene Pharmaceutical Services Ltd.
    • 2.17.1 Aurigene Pharmaceutical Services Ltd. Details
    • 2.17.2 Aurigene Pharmaceutical Services Ltd. Major Business
    • 2.17.3 Aurigene Pharmaceutical Services Ltd. New Chemical Entities (NCE) Product and Solutions
    • 2.17.4 Aurigene Pharmaceutical Services Ltd. New Chemical Entities (NCE) Revenue, Gross Margin and Market Share (2021-2026)
    • 2.17.5 Aurigene Pharmaceutical Services Ltd. Recent Developments and Future Plans
  • 2.18 Aragen Life Sciences Ltd
    • 2.18.1 Aragen Life Sciences Ltd Details
    • 2.18.2 Aragen Life Sciences Ltd Major Business
    • 2.18.3 Aragen Life Sciences Ltd New Chemical Entities (NCE) Product and Solutions
    • 2.18.4 Aragen Life Sciences Ltd New Chemical Entities (NCE) Revenue, Gross Margin and Market Share (2021-2026)
    • 2.18.5 Aragen Life Sciences Ltd Recent Developments and Future Plans
  • 2.19 WuXi AppTec
    • 2.19.1 WuXi AppTec Details
    • 2.19.2 WuXi AppTec Major Business
    • 2.19.3 WuXi AppTec New Chemical Entities (NCE) Product and Solutions
    • 2.19.4 WuXi AppTec New Chemical Entities (NCE) Revenue, Gross Margin and Market Share (2021-2026)
    • 2.19.5 WuXi AppTec Recent Developments and Future Plans
  • 2.20 PharmaBlock Sciences Nanjing Inc
    • 2.20.1 PharmaBlock Sciences Nanjing Inc Details
    • 2.20.2 PharmaBlock Sciences Nanjing Inc Major Business
    • 2.20.3 PharmaBlock Sciences Nanjing Inc New Chemical Entities (NCE) Product and Solutions
    • 2.20.4 PharmaBlock Sciences Nanjing Inc New Chemical Entities (NCE) Revenue, Gross Margin and Market Share (2021-2026)
    • 2.20.5 PharmaBlock Sciences Nanjing Inc Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global New Chemical Entities (NCE) Revenue and Share by Players (2021-2026)
  • 3.2 Market Share Analysis (2025)
    • 3.2.1 Market Share of New Chemical Entities (NCE) by Company Revenue
    • 3.2.2 Top 3 New Chemical Entities (NCE) Players Market Share in 2025
    • 3.2.3 Top 6 New Chemical Entities (NCE) Players Market Share in 2025
  • 3.3 New Chemical Entities (NCE) Market: Overall Company Footprint Analysis
    • 3.3.1 New Chemical Entities (NCE) Market: Region Footprint
    • 3.3.2 New Chemical Entities (NCE) Market: Company Product Type Footprint
    • 3.3.3 New Chemical Entities (NCE) Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global New Chemical Entities (NCE) Consumption Value and Market Share by Type (2021-2026)
  • 4.2 Global New Chemical Entities (NCE) Market Forecast by Type (2027-2032)

5 Market Size Segment by Application

  • 5.1 Global New Chemical Entities (NCE) Consumption Value Market Share by Application (2021-2026)
  • 5.2 Global New Chemical Entities (NCE) Market Forecast by Application (2027-2032)

6 North America

  • 6.1 North America New Chemical Entities (NCE) Consumption Value by Type (2021-2032)
  • 6.2 North America New Chemical Entities (NCE) Market Size by Application (2021-2032)
  • 6.3 North America New Chemical Entities (NCE) Market Size by Country
    • 6.3.1 North America New Chemical Entities (NCE) Consumption Value by Country (2021-2032)
    • 6.3.2 United States New Chemical Entities (NCE) Market Size and Forecast (2021-2032)
    • 6.3.3 Canada New Chemical Entities (NCE) Market Size and Forecast (2021-2032)
    • 6.3.4 Mexico New Chemical Entities (NCE) Market Size and Forecast (2021-2032)

7 Europe

  • 7.1 Europe New Chemical Entities (NCE) Consumption Value by Type (2021-2032)
  • 7.2 Europe New Chemical Entities (NCE) Consumption Value by Application (2021-2032)
  • 7.3 Europe New Chemical Entities (NCE) Market Size by Country
    • 7.3.1 Europe New Chemical Entities (NCE) Consumption Value by Country (2021-2032)
    • 7.3.2 Germany New Chemical Entities (NCE) Market Size and Forecast (2021-2032)
    • 7.3.3 France New Chemical Entities (NCE) Market Size and Forecast (2021-2032)
    • 7.3.4 United Kingdom New Chemical Entities (NCE) Market Size and Forecast (2021-2032)
    • 7.3.5 Russia New Chemical Entities (NCE) Market Size and Forecast (2021-2032)
    • 7.3.6 Italy New Chemical Entities (NCE) Market Size and Forecast (2021-2032)

8 Asia-Pacific

  • 8.1 Asia-Pacific New Chemical Entities (NCE) Consumption Value by Type (2021-2032)
  • 8.2 Asia-Pacific New Chemical Entities (NCE) Consumption Value by Application (2021-2032)
  • 8.3 Asia-Pacific New Chemical Entities (NCE) Market Size by Region
    • 8.3.1 Asia-Pacific New Chemical Entities (NCE) Consumption Value by Region (2021-2032)
    • 8.3.2 China New Chemical Entities (NCE) Market Size and Forecast (2021-2032)
    • 8.3.3 Japan New Chemical Entities (NCE) Market Size and Forecast (2021-2032)
    • 8.3.4 South Korea New Chemical Entities (NCE) Market Size and Forecast (2021-2032)
    • 8.3.5 India New Chemical Entities (NCE) Market Size and Forecast (2021-2032)
    • 8.3.6 Southeast Asia New Chemical Entities (NCE) Market Size and Forecast (2021-2032)
    • 8.3.7 Australia New Chemical Entities (NCE) Market Size and Forecast (2021-2032)

9 South America

  • 9.1 South America New Chemical Entities (NCE) Consumption Value by Type (2021-2032)
  • 9.2 South America New Chemical Entities (NCE) Consumption Value by Application (2021-2032)
  • 9.3 South America New Chemical Entities (NCE) Market Size by Country
    • 9.3.1 South America New Chemical Entities (NCE) Consumption Value by Country (2021-2032)
    • 9.3.2 Brazil New Chemical Entities (NCE) Market Size and Forecast (2021-2032)
    • 9.3.3 Argentina New Chemical Entities (NCE) Market Size and Forecast (2021-2032)

10 Middle East & Africa

  • 10.1 Middle East & Africa New Chemical Entities (NCE) Consumption Value by Type (2021-2032)
  • 10.2 Middle East & Africa New Chemical Entities (NCE) Consumption Value by Application (2021-2032)
  • 10.3 Middle East & Africa New Chemical Entities (NCE) Market Size by Country
    • 10.3.1 Middle East & Africa New Chemical Entities (NCE) Consumption Value by Country (2021-2032)
    • 10.3.2 Turkey New Chemical Entities (NCE) Market Size and Forecast (2021-2032)
    • 10.3.3 Saudi Arabia New Chemical Entities (NCE) Market Size and Forecast (2021-2032)
    • 10.3.4 UAE New Chemical Entities (NCE) Market Size and Forecast (2021-2032)

11 Market Dynamics

  • 11.1 New Chemical Entities (NCE) Market Drivers
  • 11.2 New Chemical Entities (NCE) Market Restraints
  • 11.3 New Chemical Entities (NCE) Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 New Chemical Entities (NCE) Industry Chain
  • 12.2 New Chemical Entities (NCE) Upstream Analysis
  • 12.3 New Chemical Entities (NCE) Midstream Analysis
  • 12.4 New Chemical Entities (NCE) Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on New Chemical Entities (NCE). Industry analysis & Market Report on New Chemical Entities (NCE) is a syndicated market report, published as Global New Chemical Entities (NCE) Market 2026 by Company, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of New Chemical Entities (NCE) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,480.00
    $5,220.00
    $6,960.00
    2,690.04
    4,035.06
    5,380.08
    3,239.88
    4,859.82
    6,479.76
    531,361.20
    797,041.80
    1,062,722.40
    293,712.00
    440,568.00
    587,424.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report